Cancer antigen 27-29 (CA 27-29) is used to predict early recurrence of disease in women with treated carcinoma of the breast. The reference range of serum CA 27-29 is less than 38 U/mL. The upper limit of the range may vary depending on the laboratory and testing kit used for the test.
Antigens like CA 27-29 that give information about cancer are called tumor markers. Breast cancer is the cancer most likely to release CA 27-29. The FDA has approved the CA 27-29 blood test as a way for healthcare providers to monitor people with breast cancer.
While the CA 27.29 reference range can vary slightly from one lab to the next, it is generally accepted that anything less than 38.6 units per millimeter (U/mL) is normal.
Immunoassay determinations of the serum levels of certain proteins or carbohydrates serve as tumor markers. When elevated, serum concentration of these markers may reflect tumor size and grade. This policy specifically addresses tumor antigen CA 125.
Generally, the higher the CA 27-29 level, the more advanced the breast cancer or larger the tumor burden. If the tumor produces CA 27-29, then tumor marker levels tend to increase as the tumor grows. The highest levels may be seen in metastatic breast cancer, particularly with metastases to the liver or the bones.
Tumor marker levels may be higher when there is cancer in the body....Guide to Tumor Markers Used in Cancer.Tumor MarkerBlood test (blood serum marker), except where noted."Normal" Results< 37 U/ml is normal > 120 U/ml is generally caused by tumorCA 125 Cancer Antigen 125 or Carbohydrate Antigen 12588 more rows
Normal range may vary somewhat depending on the brand of assay used. Levels > 10 ng/ml suggest extensive disease and levels > 20 ng/ml suggest metastatic disease.
A tumor marker is anything present in or produced by cancer cells or other cells of the body in response to cancer or certain benign (noncancerous) conditions that provides information about a cancer, such as how aggressive it is, what kind of treatment it may respond to, or whether it is responding to treatment.
What is benign breast disease? If you feel a lump in your breast, your first thought may be that you have breast cancer. Fortunately, a majority of breast lumps are benign, meaning they're not cancerous. Both women and men can develop benign (noncancerous) breast lumps. This condition is known as benign breast disease.
0 for Elevated carcinoembryonic antigen [CEA] is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
R77.2R77. 2 - Abnormality of alphafetoprotein | ICD-10-CM.
Immunoassay determinations of the serum levels of certain proteins or carbohydrates serve as tumor markers. When elevated, serum concentration of these markers may reflect tumor size and grade. This policy specifically addresses tumor antigen CA 125.
CA 27.29 may be useful for monitoring patients for metastatic breast cancer.
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering. CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering. Not offered in Quest Infectious Disease Inc. - San Juan Capistrano, CA.